9/7/2022

Misoprostol Tablets

Products Affected - Description

- Misoprostol oral tablet, Lupin, 100 mcg, bottle, 60 count, NDC 43386-0160-06 - discontinued
- Misoprostol oral tablet, Lupin, 100 mcg, bottle, 120 count, NDC 43386-0160-12 - discontinued
- Misoprostol oral tablet, Lupin, 200 mcg, bottle, 60 count, NDC 43386-0161-06 - discontinued
- Misoprostol oral tablet, Lupin, 200 mcg, bottle, 100 count, NDC 43386-0161-01 - discontinued

Reason for the Shortage

- Lupin discontinued misoprostol tablets.
- Pfizer has Cytotec tablets available.
- Greenstone (Viatris) has misoprostol tablets available.

Available Products

- Cytotec oral tablet, Pfizer, 100 mcg, bottle, 60 count, NDC 00025-1451-60
- Cytotec oral tablet, Pfizer, 100 mcg, unit-dose blister pack, 100 count, NDC 00025-1451-34
- Cytotec oral tablet, Pfizer, 200 mcg, bottle, 60 count, NDC 00025-1461-60
- Cytotec oral tablet, Pfizer, 200 mcg, bottle, 100 count, NDC 00025-1461-31
- Misoprostol oral tablet, Greenstone (Viatris), 100 mcg, bottle, 60 count, NDC 59762-5007-01
- Misoprostol oral tablet, Greenstone (Viatris), 100 mcg, bottle, 120 count, NDC 59762-5007-02
- Misoprostol oral tablet, Greenstone (Viatris), 200 mcg, bottle, 60 count, NDC 59762-5008-01
- Misoprostol oral tablet, Greenstone (Viatris), 200 mcg, bottle, 100 count, NDC 59762-5008-02

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated September 7, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 25, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.